Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

FDA approves Bristol Myers’ multiple myeloma successor

The FDA has granted accelerated approval for a Bristol Myers Squibb pill called iberdomide for patients with multiple myeloma that’s returned or stopped responding to treatment. Iberdomide is marketed as Zenbexus, and carries a list ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Read the original at endpoints.news →

More in Health & Medicine

Impaired brain protein drives fat cravings and obesity in mice

Obesity is a global health concern that can contribute to diabetes, cardiovascular disease and other metabolic disorders. While many health conditions can lead to obesity, an increasingly worrying cause is found on grocery shelves: high-fat foods. These foods are known to be hard to resist and can promote overeating.

More from Thursday 13 August →